Literature DB >> 24967972

Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4.

Cheng-Yu Tsai1, Christopher A Larson2, Roohangiz Safaei3, Stephen B Howell4.   

Abstract

The copper influx transporter CTR1 is also a major influx transporter for cisplatin (cDDP) in tumor cells. It influences the cytotoxicity of cDDP both in vivo and in vitro. Whereas Cu triggers internalization of CTR1 from the plasma membrane, cDDP does not. To investigate the mechanisms of these effects, myc-tagged forms of wild type hCTR1 and variants in which Y103 was converted to alanine, C189 was converted to serine, or the K178/K179 dilysine motif was converted to alanines were re-expressed in mouse embryo cells in which both alleles of CTR1 had been knocked out and also in HEK293T cells. The Y103A mutation and to a lesser extent the C189S mutation reduced internalization of CTR1 induced by Cu while the K178A/K179A had little effect. Both Y103 and C189 were required for Cu and cDDP transport whereas the K178/K179 motif was not. While Y103 lies in an YXXM motif that, when phosphorylated, is a potential docking site for phosphatidylinositol 3-kinase and other proteins involved in endocytosis, Western blot analysis of immunoprecipitated myc-CTR1, and proteomic analysis of peptides derived from CTR1, failed to identify any basal or Cu-induced phosphorylation. However, proteomic analysis did identify an interaction of CTR1 with IRS-4 and this was confirmed by co-immunoprecipitation from HEK cells expressing either FLAG-CTR1 or myc-CTR1. The interaction was greater in the Y103A-expressing cells. We conclude that Y103 is required for the internalization of hCTR1 in response to Cu, that this occurs by a mechanism other than phosphorylation and that mutation of Y103 modulates the interaction with IRS-4.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cisplatin; Copper transporter 1; Insulin receptor substrate 4

Mesh:

Substances:

Year:  2014        PMID: 24967972      PMCID: PMC4343213          DOI: 10.1016/j.bcp.2014.06.019

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  53 in total

1.  Characterization of a monoclonal antibody capable of reliably quantifying expression of human Copper Transporter 1 (hCTR1).

Authors:  Jacob F Quail; Cheng-Yu Tsai; Stephen B Howell
Journal:  J Trace Elem Med Biol       Date:  2013-12-18       Impact factor: 3.849

2.  Molecular characterization of hCTR1, the human copper uptake protein.

Authors:  John F Eisses; Jack H Kaplan
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

Review 3.  Insulin receptor substrate polymorphisms and type 2 diabetes mellitus.

Authors:  G Sesti
Journal:  Pharmacogenomics       Date:  2000-08       Impact factor: 2.533

4.  A C-terminal domain of the membrane copper pump Ctr1 exchanges copper(I) with the copper chaperone Atx1.

Authors:  Zhiguang Xiao; Anthony G Wedd
Journal:  Chem Commun (Camb)       Date:  2002-03-21       Impact factor: 6.222

5.  Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system.

Authors:  Jaekwon Lee; Michael J Petris; Dennis J Thiele
Journal:  J Biol Chem       Date:  2002-08-12       Impact factor: 5.157

6.  YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals.

Authors:  Haiyan Wu; David A Windmiller; Ling Wang; Jonathan M Backer
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

7.  The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

Authors:  Xinjian Lin; Tsuyoshi Okuda; Alison Holzer; Stephen B Howell
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

8.  Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1.

Authors:  Michael J Petris; Kathryn Smith; Jaekwon Lee; Dennis J Thiele
Journal:  J Biol Chem       Date:  2002-12-25       Impact factor: 5.157

Review 9.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.

Authors:  G Sesti; M Federici; M L Hribal; D Lauro; P Sbraccia; R Lauro
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

10.  Human VPS34 is required for internal vesicle formation within multivesicular endosomes.

Authors:  C E Futter; L M Collinson; J M Backer; C R Hopkins
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

View more
  12 in total

Review 1.  Copper transporters and chaperones: Their function on angiogenesis and cellular signalling.

Authors:  S R Bharathi Devi; Aloysius Dhivya M; K N Sulochana
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

Review 2.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

3.  The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2).

Authors:  Cheng-Yu Tsai; Janika K Liebig; Igor F Tsigelny; Stephen B Howell
Journal:  Metallomics       Date:  2015-07-24       Impact factor: 4.526

Review 4.  An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.

Authors:  Vojtech Dvorak; Tabea Wiedmer; Alvaro Ingles-Prieto; Patrick Altermatt; Helena Batoulis; Felix Bärenz; Eckhard Bender; Daniela Digles; Franz Dürrenberger; Laura H Heitman; Adriaan P IJzerman; Douglas B Kell; Stefanie Kickinger; Daniel Körzö; Philipp Leippe; Thomas Licher; Vania Manolova; Riccardo Rizzetto; Francesca Sassone; Lia Scarabottolo; Avner Schlessinger; Vanessa Schneider; Hubert J Sijben; Anna-Lena Steck; Hanna Sundström; Sara Tremolada; Maria Wilhelm; Marina Wright Muelas; Diana Zindel; Claire M Steppan; Giulio Superti-Furga
Journal:  Front Pharmacol       Date:  2021-08-10       Impact factor: 5.988

5.  Dynamic internalization and recycling of a metal ion transporter: Cu homeostasis and CTR1, the human Cu⁺ uptake system.

Authors:  Rebecca J Clifford; Edward B Maryon; Jack H Kaplan
Journal:  J Cell Sci       Date:  2016-03-04       Impact factor: 5.285

Review 6.  Role of transporters in the distribution of platinum-based drugs.

Authors:  Saliha Harrach; Giuliano Ciarimboli
Journal:  Front Pharmacol       Date:  2015-04-24       Impact factor: 5.810

7.  NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.

Authors:  Pan Jiang; Xiaoyue Wu; Xuemin Wang; Wenbin Huang; Qing Feng
Journal:  Oncotarget       Date:  2016-07-12

Review 8.  Crossroads between membrane trafficking machinery and copper homeostasis in the nerve system.

Authors:  Meng-Hsuan Wen; Xihong Xie; Pei-San Huang; Karen Yang; Tai-Yen Chen
Journal:  Open Biol       Date:  2021-12-01       Impact factor: 6.411

9.  Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation.

Authors:  Si Sun; Simei Zhao; Qiang Yang; Wenwen Wang; E Cai; Yiping Wen; Lili Yu; Zehua Wang; Jing Cai
Journal:  Cancer Sci       Date:  2018-05-15       Impact factor: 6.716

Review 10.  Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs.

Authors:  Ian Henry Lambert; Belinda Halling Sørensen
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.